1 ANASTROZOLE | 10 of 310 | 3390 prescriptions Less than 1% of all prescriptions | 3390 | 630 patients 24% of all patients | 630 patients 24% of all patients | |
2 HYDROXYUREA | 10 of 410 | 1860 prescriptions Less than 1% of all prescriptions | 1860 | 250 patients 9% of all patients | 250 patients 9% of all patients | |
3 EXEMESTANE | 10 of 120 | 1060 prescriptions Less than 1% of all prescriptions | | 200 patients 8% of all patients | < 11 | |
4 LETROZOLE | 60 of 170 | 700 prescriptions Less than 1% of all prescriptions | | 120 patients 5% of all patients | < 11 | |
5 IMATINIB MESYLATE | 10 of 190 | 690 prescriptions Less than 1% of all prescriptions | 690 | < 11 | < 11 | |
6 IMBRUVICA (IBRUTINIB) | 40 of 230 | 770 prescriptions Less than 1% of all prescriptions | 770 | < 11 | < 11 | |
7 IBRANCE (PALBOCICLIB) | 20 of 110 | 740 prescriptions Less than 1% of all prescriptions | 740 | < 11 | < 11 | |
8 WARFARIN SODIUM | 50 of 130 | 400 prescriptions Less than 1% of all prescriptions | 400 | < 11 | < 11 | |
9 REVLIMID (LENALIDOMIDE) | 50 of 230 | 630 prescriptions Less than 1% of all prescriptions | 630 | 130 patients 5% of all patients | 130 patients 5% of all patients | |
10 DEXAMETHASONE | 30 of 270 | 630 prescriptions Less than 1% of all prescriptions | 630 | 160 patients 6% of all patients | 160 patients 6% of all patients | |
11 TAMOXIFEN CITRATE | 30 of 180 | 330 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 PREDNISONE | 40 of 360 | 410 prescriptions Less than 1% of all prescriptions | | 140 patients 5% of all patients | < 11 | |
13 MORPHINE SULFATE ER (MORPHINE SULFATE) | 20 of 40 | 270 prescriptions Less than 1% of all prescriptions | 270 | < 11 | < 11 | O |
14 ARANESP (DARBEPOETIN ALFA IN POLYSORBAT) | 10 of 20 | 270 prescriptions Less than 1% of all prescriptions | 270 | < 11 | < 11 | |
15 GLEEVEC (IMATINIB MESYLATE) | 20 of 80 | 230 prescriptions Less than 1% of all prescriptions | 230 | < 11 | < 11 | |
16 PROCHLORPERAZINE MALEATE | 30 of 160 | 560 prescriptions Less than 1% of all prescriptions | | 410 patients 15% of all patients | < 11 | |
17 XARELTO (RIVAROXABAN) | 170 of 270 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
18 ZYTIGA (ABIRATERONE ACETATE) | 10 of 40 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 JADENU (DEFERASIROX) | 10 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 JAKAFI (RUXOLITINIB PHOSPHATE) | 100 of 130 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
21 GABAPENTIN | 130 of 200 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
22 HYDROCODONE-ACETAMINOPHEN (HYDROCODONE/ACETAMINOPHEN) | 10 of 40 | 400 prescriptions Less than 1% of all prescriptions | 400 | 160 patients 6% of all patients | 160 patients 6% of all patients | O |
23 PRADAXA (DABIGATRAN ETEXILATE MESYLATE) | 20 of 20 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
24 ALPRAZOLAM | 40 of 80 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
25 OXYCODONE-ACETAMINOPHEN (OXYCODONE HCL/ACETAMINOPHEN) | 60 of 80 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | O |
26 ONDANSETRON HCL | 110 of 240 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |